STABLE (STABLE) fluctuates 43.1% in 24 hours: rebounds from $0.02623 low to $0.03754, driven by surge in trading volume and short squeeze
Bitget Pulse2026/04/02 09:59Volatility Brief
Over the past 24 hours, STABLE’s price reached a low of $0.02623 and a high of $0.03754, with the current price at $0.03754—a total fluctuation amplitude of 43.1%. Trading volume surged notably to around $60.6 million, with a market cap of $757 million. Compared to earlier periods, trading volume has increased significantly (e.g., from $19 million to $130 million).
Summary of Abnormal Movements
• The price rebounded from the key demand zone of $0.022, accompanied by a surge in trading volume (from $19 million on March 31 to $130 million), indicating strong buying pressure entering the market.
• More than $500,000 in short liquidity in the $0.021-$0.023 range was liquidated, triggering a short squeeze and further amplifying gains.
• Early data shows strong buying pressure and potential institutional/whale accumulation, with 24-hour trading starting at $35 million.
Market Opinions and Outlook
Market sentiment is strongly bullish, with 82% of the community voting in favor of long positions. Analysts believe that if trading volume remains strong, the price could challenge the psychological resistance at $0.040, but caution is advised regarding the risk of price consolidation if momentum weakens.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hundred Billion ARR and 18.4 Billion Burn Rate: SpaceX (SPCX.US) First Quarterly Report Faces Off Between "Growth and Cost"
After the U.S. stock market closed on August 4, SpaceX released its first quarterly report since going public. Despite second-quarter revenue doubling significantly and management providing strong guidance to reach $100 billion ARR by the end of the year, the company's stock price plunged by more than 9% after hours.

Dogecoin: Is DOGE’s record-low RSI a buy signal or bull trap?

Novo Nordisk (NVO.US) Q2 results beat expectations and full-year guidance is raised, but concerns remain! Wegovy oral drug sales are weak, and the path to renewed growth is still uncertain
Although Novo Nordisk reported better-than-expected Q2 2026 results and raised its full-year guidance, it did not address the issue that is of most concern to Wall Street.

Biconomy Price Prediction: BICO Surges 126% Weekly as Bulls Target $0.03
